查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1696202

全球神经血管支架市场 - 2025 至 2033 年

Global Neurovascular Stents Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球神经血管支架市场规模达到 12.5175 亿美元，预计到 2033 年将达到 30.4053 亿美元，2025-2033 年预测期内的复合年增长率为 10.4%。

神经血管支架是植入脑血管内的小型网状管状装置，用于治疗各种神经血管疾病。它们透过强化衰弱或狭窄的动脉来帮助恢復正常血流，从而降低中风和动脉瘤破裂的风险。这些支架有不同的类型，包括用于打通阻塞脑动脉的颅内支架、用于大颈或宽颈动脉瘤的血流分流器、用于清除急性缺血性中风血栓的支架取栓器，以及用于预防颈动脉狭窄引起中风的颈动脉支架。

市场动态：

驱动因素与约束因素

神经血管疾病盛行率上升

中风、动脉瘤和颈动脉疾病等神经血管疾病的发生率不断上升，大大推动了神经血管支架市场的成长。随着全球人口老化，这些疾病的发生率正在增加，特别是在更容易患脑血管疾病的老年人身上。

缺血性中风是由于脑血流受阻而导致的，其发生率日益上升，对神经血管支架的需求也随之增加，神经血管支架作为恢復脑血流和防止进一步损害的治疗选择。例如，根据美国国立卫生研究院 2025 年的报告，研究人员估计美国约有 795,000 人患有中风，其中约 61 万人是首次发病。几乎四分之一的中风倖存者在其一生中会再次遭受中风。缺血性中风是由于脑血流受阻而发生的，约占所有中风病例的 87%。颅内挽救支架（RS）是机械血栓切除术（MT）失败后治疗急性缺血性中风的一种选择。缺血性中风患者数量的增加增加了神经血管支架手术的需求。

此外，患有颅内动脉粥样硬化和颅内动脉瘤的患者数量不断增加，也推动了用于加强脆弱血管、降低破裂风险的支架的应用。

神经血管支架手术费用高昂

神经血管支架手术的高成本是市场成长的重大障碍，特别是在医疗预算和保险覆盖有限的发展中地区。神经血管支架以及所需的影像、手术专业知识和术后护理使得整体治疗费用昂贵，手术费用因复杂性和位置而异。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按类型分类的程式码片段
  • 材料片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 神经血管疾病盛行率上升
      • 支架技术的进步
    • 限制
      • 神经血管支架手术费用高昂
      • 严格的监管审批流程
    • 机会
      • 微创手术需求不断成长
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：神经血管支架市场（按类型）

  • 颅内支架
  • 颈动脉支架

第 6 章：神经血管支架市场（按材料）

  • 聚合物
  • 金属
  • 其他的

第 7 章：神经血管支架市场（按应用）

  • 颈动脉狭窄
  • 脑动脉瘤
  • 动静脉畸形和瘻管
  • 其他的

第 8 章：神经血管支架市场（依最终用户划分）

  • 医院
  • 门诊手术中心
  • 专科诊所

第 9 章：神经血管支架市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章：公司简介

  • Stryker
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Acandis GmbH
  • Balt Group
  • Boston Scientific Corporation
  • Terumo Corporation
  • MicroPort Scientific Corporation

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: MD9362

The global neurovascular stents market reached US$ 1,251.75 million in 2024 and is expected to reach US$ 3,040.53 million by 2033, growing at a CAGR of 10.4% during the forecast period 2025-2033.

Neurovascular stents are small, mesh-like tubular devices implanted within brain blood vessels to treat various neurovascular conditions. They help restore normal blood flow by reinforcing weakened or narrowed arteries, reducing the risk of strokes and aneurysm ruptures. These stents come in different types, including intracranial stents for opening blocked brain arteries, flow diverters for large or wide-necked aneurysms, stent retrievers for removing blood clots in acute ischemic stroke, and carotid stents for preventing strokes caused by carotid artery stenosis.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Neurovascular Disorders

The rising prevalence of neurovascular disorders, such as stroke, aneurysms, and carotid artery disease, is significantly driving the growth of the neurovascular stents market. As the global population ages, the incidence of these conditions is increasing, particularly among older adults who are more vulnerable to cerebrovascular diseases.

The growing burden of ischemic strokes, which occur when blood flow to the brain is blocked, has led to a higher demand for neurovascular stents as a treatment option to restore blood flow and prevent further damage. For instance, according to a report by the National Institute of Health in 2025, it is stated that researchers estimate that approximately 795,000 people in the United States experience a stroke, with around 610,000 being first-time occurrences. Nearly 1 in 4 stroke survivors will suffer another stroke in their lifetime. Ischemic strokes, which occur due to blocked blood flow to the brain, account for about 87% of all stroke cases. Intracranial rescue stenting (RS) is an option for acute ischemic stroke after the failure of mechanical thrombectomy (MT). This increasing number of individuals with ischemic stroke individuals increases the need for neurovascular stenting procedures.

Additionally, the increasing number of patients suffering from intracranial atherosclerosis and intracranial aneurysms is fueling the adoption of stents designed to strengthen weakened blood vessels and reduce the risk of rupture.

High Cost of Neurovascular Stent Procedures

The high cost of neurovascular stent procedures is a significant barrier to market growth, particularly in developing regions where healthcare budgets and insurance coverage are limited. Neurovascular stents, along with the required imaging, surgical expertise, and post-procedure care, make the overall treatment expensive and the cost of the procedures varies depending on the complexity and location.

Segment Analysis

The global neurovascular stents market is segmented based on the type, material, application, end-user, and region.

Intracranial stents in the type segment is expected to dominate the neurovascular stents market

The intracranial stent segment is expected to dominate the global neurovascular stents market due to the rising incidence of ischemic strokes, intracranial atherosclerosis, and wide-necked aneurysms. As more patients suffer from cerebrovascular diseases, the demand for minimally invasive stenting solutions continues to grow. Intracranial stents provide a lifesaving alternative to traditional open surgeries, reducing recovery time and improving patient outcomes.

Technological advancements, such as drug-eluting and bioresorbable stents, are also driving adoption, as they help prevent complications like restenosis. Rising number of launches across various regions is expected to drive the segment's growth as these stents will be available for a vast range of individuals. For instance, in June 2024, MicroVention, Inc. announced the commercial launch of the LVIS EVO Intraluminal Support Device in the United States for the treatment of wide-neck intracranial aneurysms. The LVIS EVO, which has been available in Europe since 2019, has already seen over 12,000 units sold. Notably, it is the first fully visible coil-assist intracranial stent introduced to the U.S. market, marking a significant advancement in neurovascular treatment. Additionally, the aging global population is contributing to increased demand, as older adults are more susceptible to neurovascular conditions requiring stent placement.

Geographical Analysis

North America is expected to dominate the neurovascular stents market

North America is expected to dominate the global neurovascular stents market due to several key factors. The region has a high prevalence of neurovascular diseases, including stroke, aneurysms, and intracranial atherosclerosis, driving demand for advanced treatment options like neurovascular stents. For instance, according to the Brain Aneurysm Foundation, with approximately 1 in 50 people in the United States affected by brain aneurysms and an estimated 6.7 million Americans living with an unruptured aneurysm, the demand for neurovascular stents continues to rise, as around 30,000 individuals suffer a rupture each year, increasing the need for advanced neurovascular interventions to prevent life-threatening complications and driving the neurovascular stents market in North America.

The aging population further contributes to this demand, as older adults are at a higher risk of cerebrovascular conditions. The presence of leading medical device companies ensures continuous innovation and a strong pipeline of technologically advanced stents, including drug-eluting and bioresorbable stents. Additionally, well-established healthcare infrastructure, including specialized neurology centers and stroke care units, supports faster adoption of neurovascular stents in hospitals and clinics.

Competitive Landscape

The global market players in the neurovascular stents market are Stryker, Acandis GmbH, Balt Group, Boston Scientific Corporation, Terumo Corporation and MicroPort Scientific Corporation among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global neurovascular stents market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Neurovascular Disorders
      • 3.1.1.2. Advancements in Stent Technology
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Neurovascular Stent Procedures
      • 3.1.2.2. Stringent Regulatory Approval Processes
    • 3.1.3. Opportunity
      • 3.1.3.1. Rising Demand for Minimally Invasive Procedures
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Neurovascular Stents Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Intracranial Stents*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Carotid Artery Stents

6. Neurovascular Stents Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material
  • 6.2. Polymers*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Metal
  • 6.4. Others

7. Neurovascular Stents Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Carotid Artery Stenosis*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cerebral Aneurysms
  • 7.4. Arteriovenous Malformations and Fistulas
  • 7.5. Others

8. Neurovascular Stents Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Specialty Clinics

9. Neurovascular Stents Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Stryker*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Acandis GmbH
  • 11.3. Balt Group
  • 11.4. Boston Scientific Corporation
  • 11.5. Terumo Corporation
  • 11.6. MicroPort Scientific Corporation

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us